Hammer-Hansen, Sophia http://orcid.org/0000-0003-1298-7490
Stoltze, Ulrik http://orcid.org/0000-0001-5862-3292
Bartels, Emil
Hansen, Thomas van Overeem
Byrjalsen, Anna
Tybjærg-Hansen, Anne
Juul, Klaus
Schmiegelow, Kjeld
Tfelt, Jacob
Bundgaard, Henning
Wadt, Karin
Diness, Birgitte Rode http://orcid.org/0000-0002-9306-3419
Funding for this research was provided by:
Børnecancerfonden
Kræftens Bekæmpelse
The European Union’s Interregional Øresund–Kattegat–Skagerrak grant
Article History
Received: 4 July 2023
Revised: 2 April 2024
Accepted: 18 April 2024
First Online: 13 May 2024
Competing interests
: The authors declare no competing interests.
: Ethical approval was obtained through the regional scientific ethical committee (the Ethical Scientific Committees for the Capital Region, H-15016782) and the Danish Data Protection Agency (RH-2016-219, I-Suite no: 04804). All parents/guardians and patients 18 years or older gave formal written consent to germline WGS in the proband as well as written, informed consent to the return of actionable findings as well as scientific reporting of this. Relatives beyond parents that were referred to genetic counselling or clinical workup due to a SF gave written consent to the inclusion of their data in a scientific publication.